Related Experiment Videos
Ursodeoxycholic acid for the treatment of cholestatic diseases
1INSERM U21, Unité de Recherches Cliniques et Epidémiologiques, Villejuif, France.
Progress in Liver Diseases
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ursodeoxycholic acid and chemoprevention of colorectal cancer.
Gastroenterologie clinique et biologique·2010
The cholangiographic features of severe forms of ABCB4/MDR3 deficiency-associated cholangiopathy in adults.
Gastroenterologie clinique et biologique·2010
Differentiating between benign and non-benign obesity: look at the liver.
Gastroenterologie clinique et biologique·2010
[Cholestasis and cholestatic liver diseases].
Gastroenterologie clinique et biologique·2009
Noncirrhotic portal hypertension: recent concepts.
Progress in liver diseases·1996
Laparoscopic hepatobiliary surgery.
Progress in liver diseases·1995
Artificial hepatic support systems.
Progress in liver diseases·1995
Gene therapy for human liver disease.
Progress in liver diseases·1995
Ethanol oxidizing enzymes: roles in alcohol metabolism and alcoholic liver disease.
Progress in liver diseases·1995
Molecular biology of bilirubin metabolism.
Progress in liver diseases·1995
Bridging Worlds: Can Evidence, Regulation and Indigenous Leadership Shape the Future of Traditional, Complementary and Integrative Medicine?
The International journal of health planning and management·2026
Efficacy and safety of Qianlieshutong Capsules in the treatment for Type III prostatitis: A post-marketing, multicenter, randomized, double-blind, single-dummy, active-controlled, parallel-group clinical trial.
Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Long-mu-pi-yan-fang ameliorates atopic dermatitis-like skin inflammation by modulating interleukin-22 receptor-mediated inflammatory signaling.
Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Study on the influence of gut microbiota on the pharmacokinetics of Huoxiang Zhengqi oral liquid in rats.
Journal of pharmaceutical and biomedical analysis·2026